Podcast Anthony Letai reflects on Year One as NCI Director: “The NCI is in business” October 07, 2026
Conversation with The Cancer Letter With Year One metrics in hand, Letai is ready to “bring it home” in Year Two“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts” October 02, 2026Vol.52 No.36By Paul Goldberg
PodcastThe Directors The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want itLucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish September 25, 2026Vol.52 No.35By Claire Marie Porter and Paul Goldberg
Cancer Policy NCI launches AI tool to help match patients to clinical trials September 25, 2026Vol.52 No.35By Sara Willa Ernst
NCI Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI“To my knowledge, 100% of grants that clear my desk get funded” September 18, 2026Vol.52 No.34By Claire Marie Porter
Cancer Policy Letai shares weekly musings in NCI’s new “Tuesdays with Tony” series September 18, 2026Vol.52 No.34
In Brief Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research September 18, 2026Vol.52 No.34
In Brief UCLA researchers receive $3.9M NCI grant to boost the effectiveness of cancer immunotherapy August 07, 2026Vol.52 No.31
In Brief Dana-Farber Department of Pathology receives $2.8M grant from NCI August 07, 2026Vol.52 No.31
Cancer History ProjectFree Joseph F. Fraumeni Jr., inventor of molecular epidemiology, was a “gentle giant” who “bet on the good people”Chanock and Brawley reflect on their illustrious mentor July 31, 2026Vol.52 No.30By Sara Willa Ernst
